These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
165 related items for PubMed ID: 4019711
1. Monoclonal antibody recognition of multiple forms of estrogen receptor tagged with [125I]methoxy-iodovinyl estradiol in ovarian carcinomas. Lorincz MA, Holt JA, Greene GL. J Clin Endocrinol Metab; 1985 Sep; 61(3):412-7. PubMed ID: 4019711 [Abstract] [Full Text] [Related]
3. Binding characteristics and biological activity of 17 alpha-[125I]iodovinyl-11 beta-methoxyestradiol, an estrogen receptor-binding radiopharmaceutical, in human breast cancer cells (MCF-7). McManaway ME, Jagoda EM, Eckelman WC, Larson SM, Francis BE, Gibson RE, Reba RC, Lippman ME. Cancer Res; 1986 May; 46(5):2386-9. PubMed ID: 3697981 [Abstract] [Full Text] [Related]
5. Detection of different estrogen receptor forms in breast cancer cytosol by enzyme immunoassay. Dittadi R, Meo S, Amoroso B, Gion M. Cancer Res; 1997 Mar 15; 57(6):1066-72. PubMed ID: 9067273 [Abstract] [Full Text] [Related]
6. [125I]17-alpha-iodovinyl 11-beta-methoxyestradiol interaction in vivo with estrogen receptors in hormone-independent MCF-7 human breast cancer transfected with the v-rasH oncogene. McManaway ME, Jagoda EM, Kasid A, Eckelman WC, Francis BE, Larson SM, Gibson RE, Reba RC, Lippman ME. Cancer Res; 1987 Jun 01; 47(11):2945-9. PubMed ID: 3567911 [Abstract] [Full Text] [Related]
7. Estrogen and growth factor receptor interactions in human breast and non-small cell lung cancer cells. Pietras RJ, Márquez DC, Chen HW, Tsai E, Weinberg O, Fishbein M. Steroids; 2005 Jun 01; 70(5-7):372-81. PubMed ID: 15862820 [Abstract] [Full Text] [Related]
8. Interaction of three monoclonal antibodies with the nonactivated and activated forms of the estrogen receptor. Giambiagi N, Pasqualini JR. Endocrinology; 1990 Mar 01; 126(3):1403-9. PubMed ID: 2307111 [Abstract] [Full Text] [Related]
9. Characterization of an antiidiotypic antibody mimicking the actions of estradiol and its interaction with estrogen receptors. Mor G, Amir-Zaltsman Y, Barnard G, Kohen F. Endocrinology; 1992 Jun 01; 130(6):3633-40. PubMed ID: 1597160 [Abstract] [Full Text] [Related]
10. Evolution of immunoreactivity of monoclonal antibodies H222 and/or D547 used in the detection of breast cancer estrogen receptors. Varying reactivity of receptor isoforms. Cren H, Lechevrel C, Roussel G, Goussard J. J Steroid Biochem Mol Biol; 1991 Oct 01; 39(4A):519-27. PubMed ID: 1911441 [Abstract] [Full Text] [Related]
11. Interaction of [3H] estradiol - and [3H] monohydroxytamoxifen-estrogen receptor complexes with a monoclonal antibody. Tate AC, DeSombre ER, Greene GL, Jensen EV, Jordan VC. Breast Cancer Res Treat; 1983 Oct 01; 3(3):267-77. PubMed ID: 6671136 [Abstract] [Full Text] [Related]
12. Estrogen receptor synthesis and turnover in MCF-7 breast cancer cells measured by a density shift technique. Eckert RL, Mullick A, Rorke EA, Katzenellenbogen BS. Endocrinology; 1984 Feb 01; 114(2):629-37. PubMed ID: 6690295 [Abstract] [Full Text] [Related]
13. Antiestrogen binding in antiestrogen growth-resistant estrogen-responsive clonal variants of MCF-7 human breast cancer cells. Miller MA, Lippman ME, Katzenellenbogen BS. Cancer Res; 1984 Nov 01; 44(11):5038-45. PubMed ID: 6488162 [Abstract] [Full Text] [Related]
14. Immunological differences between the estradiol-, tamoxifen- and 4-hydroxy-tamoxifen-estrogen receptor complexes detected by two monoclonal antibodies. Giambiagi N, Pasqualini JR. J Steroid Biochem; 1988 Nov 01; 30(1-6):213-7. PubMed ID: 3386244 [Abstract] [Full Text] [Related]
15. Monoclonal antibody recognition of estrogen receptor in rabbit corpus luteum. Holt JA, Lorincz MA, King WJ. Am J Physiol; 1983 May 01; 244(5):E494-8. PubMed ID: 6189407 [Abstract] [Full Text] [Related]
16. Stromal cell-derived factor 1, a novel target of estrogen receptor action, mediates the mitogenic effects of estradiol in ovarian and breast cancer cells. Hall JM, Korach KS. Mol Endocrinol; 2003 May 01; 17(5):792-803. PubMed ID: 12586845 [Abstract] [Full Text] [Related]
17. Binding of [3H] monohydroxytamoxifen in ovarian carcinoma. Holt JA, Jordan VC, Tate AC, Lorincz MA. Br J Obstet Gynaecol; 1983 Aug 01; 90(8):751-8. PubMed ID: 6882707 [Abstract] [Full Text] [Related]
18. [I-125] 17 alpha-Iodovinyl 11 beta-methoxyestradiol: in vivo and in vitro properties of a high-affinity estrogen-receptor radiopharmaceutical. Jagoda EM, Gibson RE, Goodgold H, Ferreira N, Francis BE, Reba RC, Rzeszotarski WJ, Eckelman WC. J Nucl Med; 1984 Apr 01; 25(4):472-7. PubMed ID: 6544817 [Abstract] [Full Text] [Related]
19. Receptor binding and biological effects of three 125I-iodinated estrogen derivatives in human breast cancer cells (MCF-7). Souttou B, Moretti JL, Gros J, Guilloteau D, Crepin M. J Steroid Biochem Mol Biol; 1993 Feb 01; 44(2):105-12. PubMed ID: 8439515 [Abstract] [Full Text] [Related]
20. Ketononestrol aziridine, an agonistic estrogen receptor affinity label: study of its bioactivity and estrogen receptor covalent labeling. Elliston JF, Zablocki JA, Katzenellenbogen BS, Katzenellenbogen JA. Endocrinology; 1987 Aug 01; 121(2):667-76. PubMed ID: 3595536 [Abstract] [Full Text] [Related] Page: [Next] [New Search]